Cytogenetic Clonal Evolution in MDS Is Associated With Inferior Prognosis
The karyotype of bone marrow cells at the time of diagnosis is a strong prognostic parameter for overall survival as well as acute myeloid leukemia (AML) progression in patients with myelodysplastic syndromes (MDS). However, to the authors’ knowledge, few data exist regarding the prognostic impact of cytogenetic clonal evolution during the course of MDS. The […]
Cytogenetic Clonal Evolution in MDS Is Associated With Inferior Prognosis Read More »
